Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan-Reference-Cited by-同舟云学术

Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

Published:2018-01-30 Issue:6 Volume:107 Page:656-665
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ueda Yasutaka,Obara Naoshi,Yonemura Yuji,Noji Hideyoshi,Masuko Masayoshi,Seki Yoshinobu,Wada Katsuya,Matsuda Takahisa,Akiyama Hirozumi,Ikezoe Takayuki,Chiba Shigeru,Kanda Yoshinobu,Kawaguchi Tatsuya,Shichishima Tsutomu,Nakakuma Hideki,Okamoto Shinichiro,Nishimura Jun-ichi,Kanakura Yuzuru,Ninomiya Haruhiko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-018-2409-3/fulltext.html

Reference18 articles.

1. Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, et al. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1994;330:249–55.

2. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–62.

3. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699–709.

4. Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99:922–9.

5. Almeida AM, Bedrosian C, Cole A, Muus P, Schrezenmeier H, Szer J, et al. Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry. Intern Med J. 2017;47:1026–34.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore;Annals of the Academy of Medicine, Singapore;2024-06-28

2. Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape;Blood Reviews;2023-11

3. Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria;Annals of Hematology;2023-10-07

5. Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment;Polish Archives of Internal Medicine;2022-06-06